168 related articles for article (PubMed ID: 20053725)
1. A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation.
Chan IH; Privalsky ML
Mol Cancer Res; 2010 Jan; 8(1):15-23. PubMed ID: 20053725
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.
Chan IH; Privalsky ML
Oncogene; 2006 Jun; 25(25):3576-88. PubMed ID: 16434963
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.
Chan IH; Privalsky ML
Oncogene; 2009 Nov; 28(47):4162-74. PubMed ID: 19749797
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
Lin KH; Zhu XG; Hsu HC; Chen SL; Shieh HY; Chen ST; McPhie P; Cheng SY
Endocrinology; 1997 Dec; 138(12):5308-15. PubMed ID: 9389515
[TBL] [Abstract][Full Text] [Related]
5. An F-domain introduced by alternative splicing regulates activity of the zebrafish thyroid hormone receptor alpha.
Takayama S; Hostick U; Haendel M; Eisen J; Darimont B
Gen Comp Endocrinol; 2008 Jan; 155(1):176-89. PubMed ID: 17583703
[TBL] [Abstract][Full Text] [Related]
6. Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.
Rosen MD; Chan IH; Privalsky ML
Mol Endocrinol; 2011 Aug; 25(8):1311-25. PubMed ID: 21622534
[TBL] [Abstract][Full Text] [Related]
7. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract][Full Text] [Related]
8. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
9. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
Lin KH; Zhu XG; Shieh HY; Hsu HC; Chen ST; McPhie P; Cheng SY
Endocrinology; 1996 Oct; 137(10):4073-81. PubMed ID: 8828459
[TBL] [Abstract][Full Text] [Related]
10. The
Wejaphikul K; van Gucht ALM; Groeneweg S; Visser WE; Visser TJ; Peeters RP; Meima ME
Thyroid; 2019 Dec; 29(12):1834-1842. PubMed ID: 31530256
[No Abstract] [Full Text] [Related]
11. An RNA-binding domain in the thyroid hormone receptor enhances transcriptional activation.
Xu B; Koenig RJ
J Biol Chem; 2004 Aug; 279(32):33051-6. PubMed ID: 15180993
[TBL] [Abstract][Full Text] [Related]
12. Residues K128, 132, and 134 in the thyroid hormone receptor-alpha are essential for receptor acetylation and activity.
Sánchez-Pacheco A; Martínez-Iglesias O; Méndez-Pertuz M; Aranda A
Endocrinology; 2009 Nov; 150(11):5143-52. PubMed ID: 19819978
[TBL] [Abstract][Full Text] [Related]
13. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
Berghagen H; Ragnhildstveit E; Krogsrud K; Thuestad G; Apriletti J; Saatcioglu F
J Biol Chem; 2002 Dec; 277(51):49517-22. PubMed ID: 12388540
[TBL] [Abstract][Full Text] [Related]
14. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
Zhang X; Jeyakumar M; Bagchi MK
J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
[TBL] [Abstract][Full Text] [Related]
15. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
[TBL] [Abstract][Full Text] [Related]
16. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells.
Lin KH; Shieh HY; Chen SL; Hsu HC
Mol Carcinog; 1999 Sep; 26(1):53-61. PubMed ID: 10487522
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
18. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro: use of fluorescence polarization to assay corepressor and coactivator peptide binding.
Lévy-Bimbot M; Major G; Courilleau D; Blondeau JP; Lévi Y
Chemosphere; 2012 May; 87(7):782-8. PubMed ID: 22277881
[TBL] [Abstract][Full Text] [Related]
19. A mutant thyroid hormone receptor alpha antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation.
Liu YY; Heymann RS; Moatamed F; Schultz JJ; Sobel D; Brent GA
Endocrinology; 2007 Mar; 148(3):1206-17. PubMed ID: 17122078
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
